GB0524987D0 - Novel imaging agents for fibrosis - Google Patents

Novel imaging agents for fibrosis

Info

Publication number
GB0524987D0
GB0524987D0 GBGB0524987.5A GB0524987A GB0524987D0 GB 0524987 D0 GB0524987 D0 GB 0524987D0 GB 0524987 A GB0524987 A GB 0524987A GB 0524987 D0 GB0524987 D0 GB 0524987D0
Authority
GB
United Kingdom
Prior art keywords
fibrosis
imaging agents
novel imaging
novel
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0524987.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GBGB0524987.5A priority Critical patent/GB0524987D0/en
Publication of GB0524987D0 publication Critical patent/GB0524987D0/en
Priority to JP2008543898A priority patent/JP2009518372A/ja
Priority to EP10187178A priority patent/EP2305316A3/en
Priority to CNA2006800461919A priority patent/CN101325978A/zh
Priority to US12/095,931 priority patent/US20080279765A1/en
Priority to EP06831370A priority patent/EP1957114A2/en
Priority to PCT/GB2006/004575 priority patent/WO2007066115A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
GBGB0524987.5A 2005-12-08 2005-12-08 Novel imaging agents for fibrosis Ceased GB0524987D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0524987.5A GB0524987D0 (en) 2005-12-08 2005-12-08 Novel imaging agents for fibrosis
JP2008543898A JP2009518372A (ja) 2005-12-08 2006-12-07 線維症用の新規造影剤
EP10187178A EP2305316A3 (en) 2005-12-08 2006-12-07 Diphosphorylated glycopeptide imaging agent for fibrosis
CNA2006800461919A CN101325978A (zh) 2005-12-08 2006-12-07 用于纤维化的新显像剂
US12/095,931 US20080279765A1 (en) 2005-12-08 2006-12-07 Novel Imaging Agents for Fibrosis
EP06831370A EP1957114A2 (en) 2005-12-08 2006-12-07 Novel imaging agents for fibrosis
PCT/GB2006/004575 WO2007066115A2 (en) 2005-12-08 2006-12-07 Novel imaging agents for fibrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0524987.5A GB0524987D0 (en) 2005-12-08 2005-12-08 Novel imaging agents for fibrosis

Publications (1)

Publication Number Publication Date
GB0524987D0 true GB0524987D0 (en) 2006-01-18

Family

ID=35735731

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0524987.5A Ceased GB0524987D0 (en) 2005-12-08 2005-12-08 Novel imaging agents for fibrosis

Country Status (6)

Country Link
US (1) US20080279765A1 (https=)
EP (2) EP2305316A3 (https=)
JP (1) JP2009518372A (https=)
CN (1) CN101325978A (https=)
GB (1) GB0524987D0 (https=)
WO (1) WO2007066115A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
JP2009221164A (ja) 2008-03-17 2009-10-01 Nitto Denko Corp 肺線維症処置剤
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
GB0722650D0 (en) * 2007-11-19 2007-12-27 Ge Healthcare Ltd Novel imaging method
CA2722858C (en) 2008-04-30 2017-08-29 Siemens Medical Solutions Usa, Inc. Substrate based pet imaging agents
JP5744723B2 (ja) * 2008-09-12 2015-07-08 日東電工株式会社 線維性疾患のイメージング剤
CN101738468B (zh) * 2008-11-24 2013-03-27 中国医学科学院阜外心血管病医院 胰岛素样生长因子ⅱ受体在检测心力衰竭中的应用及试剂盒
US8058872B2 (en) 2009-05-29 2011-11-15 The Invention Science Fund I, Llc Systems, devices, methods, and compositions including functionalized ferromagnetic structures
US8106655B2 (en) * 2009-05-29 2012-01-31 The Invention Science Fund I, Llc Multiplex imaging systems, devices, methods, and compositions including ferromagnetic structures
US8154285B1 (en) 2009-05-29 2012-04-10 The Invention Science Fund I, Llc Non-external static magnetic field imaging systems, devices, methods, and compositions
US20100303733A1 (en) * 2009-05-29 2010-12-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems, devices, methods, and compositions including ferromagnetic structures
US8063636B2 (en) * 2009-05-29 2011-11-22 The Invention Science Fund I, Llc Systems, devices, methods, and compositions including targeted ferromagnetic structures
JP5950428B2 (ja) 2010-08-05 2016-07-13 日東電工株式会社 線維化組織から正常組織を再生するための組成物
JP5517306B2 (ja) * 2011-01-26 2014-06-11 日東電工株式会社 肺線維症処置剤
US8580922B2 (en) 2011-03-04 2013-11-12 Shire Human Genetic Therapies, Inc. Peptide linkers for polypeptide compositions and methods for using same
BR112013022557A2 (pt) * 2011-03-04 2017-08-01 Shire Human Genetic Therapies ligantes de peptídeo composições de polipeptídeo e métodos para uso dos mesmos
US20150320892A1 (en) * 2012-06-29 2015-11-12 Ge Healthcare Limited Imaging fibrosis
JP6340162B2 (ja) 2012-12-20 2018-06-06 日東電工株式会社 アポトーシス誘導剤
CA2944417A1 (en) 2014-04-02 2015-10-08 Nitto Denko Corporation A targeting molecule and a use thereof
EP3129425B1 (en) 2014-04-07 2019-04-10 Nitto Denko Corporation Polymer-based hydrotropes for hydrophobic drug delivery
CN105148291A (zh) * 2015-09-16 2015-12-16 中国海洋大学 多聚糖醛酸为载体的活体染色造影剂及制备方法和应用
CN105343900B (zh) * 2015-09-16 2019-04-02 中国海洋大学 褐藻多糖为载体的淋巴靶向核磁造影剂及制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885363A (en) 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US5217705A (en) * 1987-09-25 1993-06-08 Neorx Corporation Method of diagnosing blood clots using fibrin-binding proteins
ES2070329T3 (es) 1989-07-20 1995-06-01 Sandoz Ltd Derivados de polipeptidos.
DK129293D0 (da) 1993-11-16 1993-11-16 Carlsberg Lab Carbonhydratholdige forbindelser, der kan binde sig til carbonhydratbindende receptorer
US6908903B1 (en) * 1994-12-07 2005-06-21 Aletheon Pharmaceuticals, Inc. Cluster clearing agents
CA2345932C (en) 1998-10-08 2010-07-13 Stichting Voor De Technische Wetenschappen Peptide-based carrier devices for stellate cells
ATE384736T1 (de) * 2001-04-30 2008-02-15 Zystor Therapeutics Inc Subzelluläres targeting von therapeutischen proteinen
GB0115927D0 (en) 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
GB0115929D0 (en) 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase electrophilic fluorination
GB0206750D0 (en) 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
CN1767860A (zh) * 2003-01-31 2006-05-03 免疫医疗公司 施用治疗和诊断剂的方法和组合物
DE60319354T2 (de) 2003-07-11 2009-03-26 Lbr Medbiotech B.V. Mannose-6-Phosphat Rezeptor vermittelter Gentransfer zu Muskelzellen
JP2007512321A (ja) * 2003-11-24 2007-05-17 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
US20060148740A1 (en) * 2005-01-05 2006-07-06 Prosensa B.V. Mannose-6-phosphate receptor mediated gene transfer into muscle cells

Also Published As

Publication number Publication date
WO2007066115B1 (en) 2008-01-31
EP1957114A2 (en) 2008-08-20
WO2007066115A3 (en) 2007-11-29
WO2007066115A2 (en) 2007-06-14
CN101325978A (zh) 2008-12-17
EP2305316A2 (en) 2011-04-06
US20080279765A1 (en) 2008-11-13
JP2009518372A (ja) 2009-05-07
EP2305316A3 (en) 2011-06-08

Similar Documents

Publication Publication Date Title
GB0519391D0 (en) Imaging agents
GB2424581B (en) Formulations
GB0524987D0 (en) Novel imaging agents for fibrosis
IL188704A0 (en) Image blending
GB0610395D0 (en) Novel imaging agents
PL1917342T3 (pl) Środki czyszczące
GB2410566B (en) Imaging members
IL185773A0 (en) Formulations
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
GB0511096D0 (en) Laser imaging
GB0517992D0 (en) Laser imaging
EP1951693A4 (en) SOLID FORMULATIONS
GB0524991D0 (en) Novel imaging agents for fibrosis
GB0512770D0 (en) Imaging compounds
EP1860475A4 (en) IMAGING LENS
GB0502277D0 (en) Novel imaging agents
GB0515803D0 (en) Intermediate compounds
GB2426071B (en) Document imaging
GB0522112D0 (en) Novel imaging agents for cancer
GB0523634D0 (en) Solid cleaning formulations
GB0524605D0 (en) Frames
GB2422543B (en) Louse-killing agents
GB0521514D0 (en) Laser imaging
EG24468A (en) Roylacid & Jatrocid
GB0525753D0 (en) Yoke

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)